BIO Statement on Changes Announced to the U.S. Childhood Vaccine Schedule
WASHINGTON, D.C. – John F. Crowley, President and CEO of the Biotechnology Innovation Organization (BIO) released the following statement on changes announced to the US childhood vaccine schedule.
“American health is as unique as America itself. The US vaccination schedule is the result of decades of a rigorous, public-facing, science-based process. The US schedule considers US epidemiology, our healthcare system strengths and challenges, and the economic impact of infectious diseases on the American people.
“Today, that America first gold standard was upended with a wholesale change to the schedule without any clear medical or scientific reason.
“Weakening recommendations for vaccines in the name of ideology over epidemiology undermines America’s leadership in public health and trust in our health authorities. It stokes fear and confusion among parents and health care providers. Most importantly, instead of making America healthy again, these actions increase the risk of serious illness for all Americans, especially children. Enough is enough. We must return to decisions guided by medical expertise and scientific evidence.”
###
About the Biotechnology Innovation Organization (BIO)
BIO is the premier biotechnology advocacy organization representing biotech companies, industry leaders, and state biotech associations in the United States and more than 35 countries around the globe. BIO members range from biotech start-ups to some of the world’s largest biopharmaceutical companies – all united by the same goal: to develop medical and scientific breakthroughs that prevent and fight disease, restore health, and improve patients’ lives. BIO also organizes the BIO International Convention and a series of annual conferences that drive partnerships, investment, and progress within the sector. Learn more at bio.org.